Toxicology Consulting Market Research Report Information by Type (Risk Mitigation Strategy Services, Forensic Investigation Services, Regulatory Advisory Services, Litigation Support Services), Application (Pharmaceutical, Biotechnology, Medical Instruments, Others), by end user (Pharmaceutical Companies, Medical Device Manufacturers, and Research Institutions) and By Region (North America, Europe, Asia-Pacific, And Rest of The World) - Forecast Till 2032

Global Toxicology Consulting Market Overview

The Toxicology Consulting Market size was valued at USD 13.62 billion in 2022 and is projected to grow from USD 15.67 Billion in 2023 to USD 55.51 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 15.09% during the forecast period (2023 - 2032). Advancement in toxicology techniques, and growing pharma R&D expenditure are driving the market growth.  

Toxicology Consulting Market Trends

• Advancement in Toxicology Techniques to Boost the Market Growth

Toxicology is distinguished by an advanced understanding of the human biological system and its disorders at the molecular level, while minimizing the risks associated with human and animal investigations. In-vitro and in-silico testing procedures are increasingly being used to replace in-vivo approaches. It also includes experiments on complete living species rather than dead organisms. Furthermore, the necessity to diagnose diseases at the molecular level, as well as screen substances in the pharmaceutical business to uncover biological capabilities with minimal side effects, has rendered the in-vivo method ineffective.

As a result of advancements in different technologies, such as cellular imaging technologies, cell culture technologies, and toxicogenomic for the procedure in a controlled environment, the in-vitro testing approach is evolving. It also contributes to advancements in 3D cell culture technologies, which enable toxicity testing to construct complex models that can replicate in-vivo systems. Hence, advancements in the field of toxicology are positively impacting the growth of the Toxicology Consulting Market during the forecast period.

The U.S. is anticipated to hold a leading position in the North American toxicology laboratories marketplace over the forecast period owing to the existence of established market players. according to Regulatory Affairs Professionals Society (RAPS), 50 novel drugs were approved by Center for Drug Evaluation and Research (CDER) in 2021, among which 38 drugs were approved in the US).

Furthermore, according to the NFLIS-Tox 2021 Survey of Toxicology Laboratories, the data from the national forensic laboratory information system show that 44% of the toxicology labs that responded to the survey were privately owned and run, while 56% of them were government supported (Figure 1). The 115 publicly funded TLs that responded to the study were made up of 46% state toxicology labs and 36% county toxicology labs. The question addressing the primary clients they serve was answered by an additional 84 private TLs. 22 (26%) of them claimed to provide services to patients who were associated with hospitals.

Toxicology Consulting Market Segment Insights

Toxicology Consulting Type Insights

The Market segments of Toxicology Consulting, based on type includes risk mitigation strategy services, forensic investigation services, regulatory advisory services, and litigation support services. The risk mitigation strategy services segment is to hold the majority share in 2022 in the Toxicology Consulting Market revenue. This is due to the approvals of an increased trend of outsourcing, and a rise in pharma R&D expenditure.

April 2019: SLR Consulting (UK) has expanded its risk assessment and toxicology services to the Asia Pacific region. with the introduction of a risk assessment and toxicology team, led by Tarah Hagen. The addition of its risk assessment and toxicology team aligns with the company’s strategy of strengthening and diversifying existing services in other geographies.

Toxicology Consulting Application Insights

The Toxicology Consulting Market segmentation is based on an application that includes pharmaceutical, biotechnology, medical instruments, and others. The pharmaceutical segment dominated the market in 2022 with respect to the Market revenue of Toxicology Consulting. This is due to the use of toxicology testing for analyzing the pharmacokinetic properties of pharmaceutical drugs. As both novel and generic drugs require assays for toxicology testing.

Toxicology Consulting End User Insights

The Market segmentation of Toxicology Consulting is based on an end user that includes pharmaceutical companies, medical device manufacturers, and research institutions. The pharmaceutical companies segment dominated the market in 2022 with respect to the Toxicology Consulting Market revenue. This is due to the use of toxicology testing for analyzing the pharmacokinetic properties of pharmaceutical drugs and rising design, implementation, and management of nonclinical testing programs. As both novel and generic drugs require assays for toxicology testing.

Figure 2: Toxicology Consulting Market, by Application, 2022 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Toxicology Consulting Regional Insights

By Region, the study segments the market into North America, Europe, Asia-Pacific, and the Rest of the World. North America toxicology consulting held the largest market share in 2022. This is attributed to the rising government funding for research of therapeutics and increased healthcare expenditure. Further, the major countries studied are the US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil. Increasing demand for quality medical healthcare is expected to fuel regional market growth.

Figure 3: TOXICOLOGY CONSULTING MARKET SHARE BY REGION 2022 & 2032

Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Europe toxicology consulting market accounts for the second-largest market share due to the strong regulatory framework for approval has increased the demand as well as the adoption of in-vitro testing methods in this region’s market. Further, the Germany market of toxicology consulting held the largest market share, and the UK market of toxicology consulting was the fastest-growing market in the European region.

The Asia-Pacific toxicology consulting market is expected to grow at a significant growth rate during the forecast period. This is due to rapid economic development in the region, and the growth and modernization of healthcare are some of the factors contributing to the growth of the Asia-Pacific regional market. In addition, rapid economic development and increasing government healthcare investments are projected to attract foreign investments in this region. Moreover, the China market of toxicology consulting held the largest market share, and the India market of toxicology consulting was the fastest-growing market in the Asia-Pacific region. Hence, Asia-Pacific is anticipated to register the highest growth rate over the forecast period from 2023–2032.

Toxicology Consulting Key Market Players & Competitive Insights

The market of Toxicology Consulting is characterized by the presence of many global, regional, and local vendors catering to the demand created by research scientists and pharmaceutical and biotechnology companies operating in the industry. The market comprises tier-1, tier-2, and local players. The tier-1 and tier-2 players have reached across the globe with diverse product portfolios. 

Companies such as Evalueserve (Switzerland), Gad Consulting (US), InterBioTox (Slovakia), and Intertek (UK) dominate the market of Toxicology Consulting due to product differentiation, financial stability, strategic developments, and diversified regional presence. The players are focused on investing in extensive research and development as well. Furthermore, they adopt strategic growth initiatives, such as expansion, product launches, joint ventures, and partnerships, to strengthen their market position and capture a large customer base.

Intertek (UK) is a global provider of total quality assurance. It offers cutting-edge and customized assurance, testing, inspection, and certification solutions for our customers' supply chains and operations. The business has a network of more than a thousand laboratories and offices spread over more than a hundred nations. A crucial component of the FTSE 100 corporation Intertek Group, Intertek UK & Ireland employs over 2,000 scientists, engineers, and technicians across 59 labs and sites around the UK. 

The business provides services to major UK supermarkets, home appliance manufacturers, oil and gas companies, and UK government agencies. It operates across North and South America, Asia, the Pacific, Europe, the Middle East, and Africa. In May 2019, Intertek expands pharmaceutical toxicology facility services as global demand increases for specialist inhalation and nasal product development for biologics. The facility will provide a dedicated laboratory space focused on formulation development of inhaled biologics to meet increasing demand from clients globally.

Key Companies in the Market of Toxicology Consulting Include

• Evalueserve (Switzerland)


• Gad Consulting (US)


• InterBioTox (Slovakia)


• Intertek (UK)


• JS Held (US)


• PinPoint Testing, LLC (US)


• Sharp HealthCare (US)


• SLR Consulting (UK)


• ToxServices (US)


• CTEH (US)

Toxicology Consulting Industry Developments

April 2019: J.S. Held expanded EH&S and Forensic Engineering Practices with the Purchase of GT Engineering & Veritox, Inc. (US) By bringing on PhD toxicologists and industrial hygienists, material scientists, and engineers, the expansion strengthens one of its fundamental tenets of offering top-notch technical competence.

Toxicology Consulting Market Segmentation

Toxicology Consulting Type Outlook

• Risk Mitigation Strategy Services


• Forensic Investigation Services


• Regulatory Advisory Services


• Litigation Support Services

Toxicology Consulting Application Outlook

• Pharmaceutical


• Biotechnology


• Medical Instruments


• Others

Toxicology Consulting End User Outlook

• Pharmaceutical Companies


• Medical Device Manufacturers


• Research Institutions

Toxicology Consulting Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America